Breast Cancer Screening and Diagnosis, NCCN clinical practice guidelines in oncology – Breast Cancer Screening and Diagnosis
https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdfColorectal Cancer Screening, NCCN clinical practice guidelines in oncology – Colorectal Cancer Screening
https://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdfLung Cancer Screening, NCCN clinical practice guidelines in oncology – Lung Cancer Screening
https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdfNCCN Guidelines Colorectal Cancer Screening, NCCN clinical practice guidelines in oncology – Colorectal Cancer Screening
https://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdfNCCN Guidelines Lung Cancer Screening, NCCN clinical practice guidelines in oncology – Lung Cancer Screening
https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdfNCCN Guidelines Breast Cancer Screening and Diagnosis, NCCN clinical practice guidelines in oncology – Breast Cancer Screening and Diagnosis
https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdfNCCN Guidelines for Patients Breast Cancer Screening and Diagnosis, These NCCN Guidelines for Patients® are based on the NCCN Clinical Practice Guidelines in Oncology. (NCCN Guidelines®) for – Breast Cancer Screening and Diagnosis
https://www.nccn.org/patients/guidelines/content/PDF/breastcancerscreening-patient.pdfNCCN Guidelines for Patients Colorectal Cancer Screening, These NCCN Guidelines for Patients® are based on the NCCN Clinical Practice Guidelines in Oncology. (NCCN Guidelines®) for – Colorectal Cancer Screening
https://www.nccn.org/patients/guidelines/content/PDF/colorectal-screening-patient.pdfNCCN Guidelines for Patients Lung Cancer Screening, These NCCN Guidelines for Patients® are based on the NCCN Clinical Practice Guidelines in Oncology. (NCCN Guidelines®) for – Lung Cancer Screening
https://www.nccn.org/patients/guidelines/content/PDF/lung_screening-patient.pdfResume Screening, Screening and Diagnosis Colorectal Cancer Screening Genetic/Familial High-Risk Assessment: Breast, , and Gastric Lung Cancer Screening Prostate Cancer Early Detection Adult Cancer, Breast Cancer Breast Cancer - Metastatic Breast Cancer Breast Cancer Screening and Diagnosis, Screening Cutaneous B-Cell Lymphomas Cutaneous T-Cell Lymphomas Diffuse Large B-Cell Lymphomas, Effects: Immune Checkpoint Inhibitors Kidney Cancer Liver Cancer Lung Cancer Screening Mantle
https://www.nccn.org/covid-19/resume-screeningPatient Webinar Breast Cancer Screening, webinar for those interested in learning more about Breast Cancer Screening. Experts discussed how to understand the purpose of breast cancer screening and the options for those at average risk, factors, -making: Discuss breast cancer screening and breast cancer risk with your health care provider(s). The most recent Patient Webinar: Breast Cancer Screening occurred in February 2024, Screening and Diagnosis. The NCCN Guidelines for Patients are available to read and download for free
https://www.nccn.org/patientresources/patient-resources/patient-webinars/patient-webinar-breast-cancer-screeningDownload a printable flyer about the Breast Cancer Screening webinar to share with others!, Tuesday, February 27, 2024 • 3:00 – 4:15 pm EST Free Patient Webinar Breast Cancer Screening Join the experts As they discuss breast cancer screening. This webinar is designed to help participants: • Understand the purpose of breast cancer screening and the options for those at average, in shared decision-making: Discuss breast cancer screening and breast cancer risk with your health care provider(s). Agenda • Introduction • Expert discussion of Breast Cancer Screening • Question
https://www.nccn.org/docs/default-source/patient-resources/webinar-flyer/download-a-printable-flyer-about-the-breast-cancer-screening-webinar-to-share-with-others!.pdf?sfvrsn=615a868f_4General Survivorship Principles: Screening for Subsequent New Primary Cancers
https://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdfThermometer Screening Tool Translation Distress Thermometer Screening Tool Version 2.2024 (Afrikaans) Distress Thermometer Screening Tool Version 2.2022 (Albanian) Distress Thermometer Screening Tool Version 2.2022 (Amharic) Distress Thermometer Screening Tool Version 2.2024 (Arabic) Distress Thermometer Screening Tool Version 2.2022 (Armenian) Distress Thermometer Screening Tool Version 2.2022 (Bengali/Bangla) Distress
https://www.nccn.org/global/what-we-do/distress-thermometer-tool-translationsacross the breast cancer (BC) continuum including, but not limited to, screening, diagnosis, treatment, funding for Quality Improvement projects to enhance breast cancer care across screening, diagnosis
https://www.nccn.org/education-research/nccn-oncology-research-program/nccn-and-novartis-request-for-proposals-(rfp)-for-the-patient-centered-quality-improvement-across-the-breast-cancer-continuumScreening through Survivorship on December 5, 2023. To view a broader list of advocacy and support, N T ADVOCACY SUMMIT: Navigating the Care Continuum from Screening through Survivorship Contents
https://www.nccn.org/docs/default-source/oncology-policy-program/pas-december-2023-toolkit.pdf?sfvrsn=94e5d61a_1should be based on the best available evidence for prevention, screening, diagnosis, treatment, Practice Guidelines, and the American Cancer Society Guidelines for Cancer Screening and Prevention, Resources for Cancer Care (2020 Standards) Ensure access to preventive screening, genetic testing, and genomic testing. Ensure access to evidence-based cancer screenings, evidence-based genetic, -to-date information for age appropriate screenings and surveillance. Require carriers to utilize NCCN
https://www.nccn.org/business-policy/business/employer-resources/employer-toolkit, health systems have begun initiatives to improve health system screening for Health-Related Social, i o n s to integrate HRSN screening. The Healthy People 2030 Initiative by the Department of Health, for Medicare and Medicaid Services (CMS) has proposed implementation of the quality measures “Screening, Thermometer and Problem List, the PRAPA R E Screening Tool ® , and the Accountable Health Communities Screening Tool. A number of states have also taken steps to address the needs of Medicaid
https://www.nccn.org/docs/default-source/oncology-policy-program/hrsn-wg-recommendations.pdf?sfvrsn=444faf60_4Cancer Screening and Diagnosis Panel, Colorectal Cancer Screening Panel, Lung Cancer Screening Panel
https://www.nccn.org/education-research/continuing-education-(ce)/nccn-guidelines-in-practice/nccn-guidelines-panelsCancer Screening and Diagnosis Version: 2.2025 Colorectal Cancer Screening Version: 1.2024, Lung Cancer Screening Version: 1.2025
https://www.nccn.org/guidelines/category_2